Literature DB >> 16388326

Psychological adjustment and knowledge about hereditary hemochromatosis in a clinic-based sample: a prospective study.

Bettina Meiser1, Stewart Dunn, Jeannette Dixon, Lawrie W Powell.   

Abstract

This study assessed psychological adjustment and quality of life relative to population-based norms and knowledge about hereditary hemochromatosis in a sample of 101 patients who attended a hemochromatosis clinic. Participants were assessed prior to their clinic visit, and two weeks and 12 months after attendance, using self-administered questionnaires. Mean Mental Health Component Scores from the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) (45.3, 95% CI 43.2, 47.4) were as compromised as those found amongst stroke victims (45.9, 95% CI 42.8, 49.0) who had participated in a national health survey. Recall of the genetic testing result was less than optimal, in that only 69.3% of those with genetic testing results knew whether they carried one or two mutations. This study demonstrates that patients would benefit from routine assessment of psychological distress and referral to mental health professionals of those whose levels of distress suggest a need for clinical intervention. Results also show that patients may benefit from strategies aimed at improving recall of genetic testing results.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16388326     DOI: 10.1007/s10897-005-6192-y

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  37 in total

1.  A descriptive study of breast cancer worry.

Authors:  K D McCaul; A D Branstetter; S M O'Donnell; K Jacobson; K B Quinlan
Journal:  J Behav Med       Date:  1998-12

2.  Psychometric properties of the Impact of Event Scale amongst women at increased risk for hereditary breast cancer.

Authors:  B Thewes; B Meiser; I B Hickie
Journal:  Psychooncology       Date:  2001 Nov-Dec       Impact factor: 3.894

3.  The impact of population based screening for carriers of cystic fibrosis.

Authors:  H Bekker; G Denniss; M Modell; M Bobrow; T Marteau
Journal:  J Med Genet       Date:  1994-05       Impact factor: 6.318

4.  Penetrance of 845G--> A (C282Y) HFE hereditary haemochromatosis mutation in the USA.

Authors:  Ernest Beutler; Vincent J Felitti; James A Koziol; Ngoc J Ho; Terri Gelbart
Journal:  Lancet       Date:  2002-01-19       Impact factor: 79.321

5.  Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing.

Authors:  C Lerman; C Hughes; R T Croyle; D Main; C Durham; C Snyder; A Bonney; J F Lynch; S A Narod; H T Lynch
Journal:  Prev Med       Date:  2000-07       Impact factor: 4.018

6.  A population-based study of the clinical expression of the hemochromatosis gene.

Authors:  J K Olynyk; D J Cullen; S Aquilia; E Rossi; L Summerville; L W Powell
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

7.  Acceptance of neonatal genetic screening for hereditary hemochromatosis by informed parents.

Authors:  M Bassett; C Dunn; K Battese; M Peek
Journal:  Genet Test       Date:  2001

8.  Implementation of HaemScreen, a workplace-based genetic screening program for hemochromatosis.

Authors:  A E Nisselle; M B Delatycki; V Collins; S Metcalfe; M A Aitken; D du Sart; J Halliday; I Macciocca; A Wakefield; V Hill; A Gason; B Warner; V Calabro; R Williamson; K J Allen
Journal:  Clin Genet       Date:  2004-05       Impact factor: 4.438

9.  Attitudes to prophylactic surgery and chemoprevention in Australian women at increased risk for breast cancer.

Authors:  B Meiser; P Butow; M Price; B Bennett; G Berry; K Tucker
Journal:  J Womens Health (Larchmt)       Date:  2003-10       Impact factor: 2.681

10.  Tailoring communication in consultations with women from high risk breast cancer families.

Authors:  E A Lobb; P N Butow; B Meiser; A Barratt; C Gaff; M A Young; J Kirk; G K Suthers; K Tucker
Journal:  Br J Cancer       Date:  2002-08-27       Impact factor: 7.640

View more
  12 in total

1.  Assessment of psychosocial outcomes in genetic counseling research: an overview of available measurement scales.

Authors:  Nadine A Kasparian; Claire E Wakefield; Bettina Meiser
Journal:  J Genet Couns       Date:  2007-08-13       Impact factor: 2.537

Review 2.  Ethical issues of predictive genetic testing for diabetes.

Authors:  Susanne B Haga
Journal:  J Diabetes Sci Technol       Date:  2009-07-01

3.  Considerations for the impact of personal genome information: a study of genomic profiling among genetics and genomics professionals.

Authors:  Julianne M O'Daniel; Susanne B Haga; Huntington F Willard
Journal:  J Genet Couns       Date:  2010-03-30       Impact factor: 2.537

4.  Defining Our Clinical Practice: The Identification of Genetic Counseling Outcomes Utilizing the Reciprocal Engagement Model.

Authors:  Krista Redlinger-Grosse; Patricia McCarthy Veach; Stephanie Cohen; Bonnie S LeRoy; Ian M MacFarlane; Heather Zierhut
Journal:  J Genet Couns       Date:  2015-07-25       Impact factor: 2.537

5.  A new approach to assessing affect and the emotional implications of personal genomic testing for common disease risk.

Authors:  Suzanne C O'Neill; Kenneth P Tercyak; Chanza Baytop; Sharon Hensley Alford; Colleen M McBride
Journal:  Public Health Genomics       Date:  2015-01-21       Impact factor: 2.000

6.  A prospective, longitudinal study of the impact of GJB2/GJB6 genetic testing on the beliefs and attitudes of parents of deaf and hard-of-hearing infants.

Authors:  Christina G S Palmer; Ariadna Martinez; Michelle Fox; Jin Zhou; Nina Shapiro; Yvonne Sininger; Wayne W Grody; Lisa A Schimmenti
Journal:  Am J Med Genet A       Date:  2009-06       Impact factor: 2.802

7.  Effect of communicating DNA based risk assessments for Crohn's disease on smoking cessation: randomised controlled trial.

Authors:  Gareth J Hollands; Sophia C L Whitwell; Richard A Parker; Natalie J Prescott; Alastair Forbes; Jeremy Sanderson; Christopher G Mathew; Cathryn M Lewis; Sally Watts; Stephen Sutton; David Armstrong; Ann Louise Kinmonth; A Toby Prevost; Theresa M Marteau
Journal:  BMJ       Date:  2012-07-20

8.  Should HFE p.C282Y homozygotes with moderately elevated serum ferritin be treated? A randomised controlled trial comparing iron reduction with sham treatment (Mi-iron).

Authors:  Sim Yee Ong; Lara Dolling; Jeannette L Dixon; Amanda J Nicoll; Lyle C Gurrin; Michelle Wolthuizen; Erica M Wood; Greg J Anderson; Grant A Ramm; Katrina J Allen; John K Olynyk; Darrell Crawford; Jennifer Kava; Louise E Ramm; Paul Gow; Simon Durrant; Lawrie W Powell; Martin B Delatycki
Journal:  BMJ Open       Date:  2015-08-12       Impact factor: 2.692

9.  Quality of life scores differs between genotypic groups of patients with suspected hereditary hemochromatosis.

Authors:  Paula Fernanda Silva Fonseca; Rodolfo Delfini Cançado; Flavio Augusto Naoum; Carla Luana Dinardo; Guilherme Henrique Hencklain Fonseca; Sandra Fatima Menosi Gualandro; José Eduardo Krieger; Alexandre Costa Pereira; Pierre Brissot; Paulo Caleb Junior Lima Santos
Journal:  BMC Med Genet       Date:  2018-01-05       Impact factor: 2.103

10.  Patients' understanding of genetic susceptibility testing in mainstream medicine: qualitative study on thrombophilia.

Authors:  Paula M Saukko; Sian Ellard; Suzanne H Richards; Maggie H Shepherd; John L Campbell
Journal:  BMC Health Serv Res       Date:  2007-06-12       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.